Rheumatoid Arthritis Drugs Market - Global Outlook and Forecast 2021-2027

Code: RW00014584989
Market Monitor Global
Oct-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Rheumatoid Arthritis Drugs in global, including the following market information:
Global Rheumatoid Arthritis Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Rheumatoid Arthritis Drugs Market Sales, 2016-2021, 2022-2027, (MT)
Global top five Rheumatoid Arthritis Drugs companies in 2020 (%)
The global Rheumatoid Arthritis Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rheumatoid Arthritis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatoid Arthritis Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Rheumatoid Arthritis Drugs Market Segment Percentages, By Type, 2020 (%)
Prescription Drugs
Over-the-counter Drugs

Global Rheumatoid Arthritis Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Rheumatoid Arthritis Drugs Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Nursing Home
Other

Global Rheumatoid Arthritis Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (MT)
Global Rheumatoid Arthritis Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rheumatoid Arthritis Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Rheumatoid Arthritis Drugs revenues share in global market, 2020 (%)
Key companies Rheumatoid Arthritis Drugs sales in global market, 2016-2021 (Estimated), (MT)
Key companies Rheumatoid Arthritis Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Bayer
Biogen
Boehringer Ingelheim
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson and Johnson
Merck
Mitsubishi Tanabe Pharma
Novartis
Pfizer
UCB S.A

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Rheumatoid Arthritis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rheumatoid Arthritis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rheumatoid Arthritis Drugs Overall Market Size
2.1 Global Rheumatoid Arthritis Drugs Market Size: 2021 VS 2027
2.2 Global Rheumatoid Arthritis Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Rheumatoid Arthritis Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Rheumatoid Arthritis Drugs Players in Global Market
3.2 Top Global Rheumatoid Arthritis Drugs Companies Ranked by Revenue
3.3 Global Rheumatoid Arthritis Drugs Revenue by Companies
3.4 Global Rheumatoid Arthritis Drugs Sales by Companies
3.5 Global Rheumatoid Arthritis Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Rheumatoid Arthritis Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Rheumatoid Arthritis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Rheumatoid Arthritis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Rheumatoid Arthritis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Rheumatoid Arthritis Drugs Market Size Markets, 2021 & 2027
4.1.2 Prescription Drugs
4.1.3 Over-the-counter Drugs
4.2 By Type - Global Rheumatoid Arthritis Drugs Revenue & Forecasts
4.2.1 By Type - Global Rheumatoid Arthritis Drugs Revenue, 2016-2021
4.2.2 By Type - Global Rheumatoid Arthritis Drugs Revenue, 2022-2027
4.2.3 By Type - Global Rheumatoid Arthritis Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Rheumatoid Arthritis Drugs Sales & Forecasts
4.3.1 By Type - Global Rheumatoid Arthritis Drugs Sales, 2016-2021
4.3.2 By Type - Global Rheumatoid Arthritis Drugs Sales, 2022-2027
4.3.3 By Type - Global Rheumatoid Arthritis Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Rheumatoid Arthritis Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rheumatoid Arthritis Drugs Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Nursing Home
5.1.5 Other
5.2 By Application - Global Rheumatoid Arthritis Drugs Revenue & Forecasts
5.2.1 By Application - Global Rheumatoid Arthritis Drugs Revenue, 2016-2021
5.2.2 By Application - Global Rheumatoid Arthritis Drugs Revenue, 2022-2027
5.2.3 By Application - Global Rheumatoid Arthritis Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Rheumatoid Arthritis Drugs Sales & Forecasts
5.3.1 By Application - Global Rheumatoid Arthritis Drugs Sales, 2016-2021
5.3.2 By Application - Global Rheumatoid Arthritis Drugs Sales, 2022-2027
5.3.3 By Application - Global Rheumatoid Arthritis Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Rheumatoid Arthritis Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Rheumatoid Arthritis Drugs Market Size, 2021 & 2027
6.2 By Region - Global Rheumatoid Arthritis Drugs Revenue & Forecasts
6.2.1 By Region - Global Rheumatoid Arthritis Drugs Revenue, 2016-2021
6.2.2 By Region - Global Rheumatoid Arthritis Drugs Revenue, 2022-2027
6.2.3 By Region - Global Rheumatoid Arthritis Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Rheumatoid Arthritis Drugs Sales & Forecasts
6.3.1 By Region - Global Rheumatoid Arthritis Drugs Sales, 2016-2021
6.3.2 By Region - Global Rheumatoid Arthritis Drugs Sales, 2022-2027
6.3.3 By Region - Global Rheumatoid Arthritis Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Rheumatoid Arthritis Drugs Revenue, 2016-2027
6.4.2 By Country - North America Rheumatoid Arthritis Drugs Sales, 2016-2027
6.4.3 US Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.4.4 Canada Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.4.5 Mexico Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Rheumatoid Arthritis Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Rheumatoid Arthritis Drugs Sales, 2016-2027
6.5.3 Germany Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.5.4 France Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.5.5 U.K. Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.5.6 Italy Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.5.7 Russia Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.5.9 Benelux Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Rheumatoid Arthritis Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Rheumatoid Arthritis Drugs Sales, 2016-2027
6.6.3 China Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.6.4 Japan Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.6.5 South Korea Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.6.7 India Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Rheumatoid Arthritis Drugs Revenue, 2016-2027
6.7.2 By Country - South America Rheumatoid Arthritis Drugs Sales, 2016-2027
6.7.3 Brazil Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.7.4 Argentina Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Rheumatoid Arthritis Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Rheumatoid Arthritis Drugs Sales, 2016-2027
6.8.3 Turkey Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.8.4 Israel Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Rheumatoid Arthritis Drugs Market Size, 2016-2027
6.8.6 UAE Rheumatoid Arthritis Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Rheumatoid Arthritis Drugs Major Product Offerings
7.1.4 AbbVie Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.1.5 AbbVie Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Rheumatoid Arthritis Drugs Major Product Offerings
7.2.4 Amgen Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Amgen Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Rheumatoid Arthritis Drugs Major Product Offerings
7.3.4 Bayer Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Bayer Key News
7.4 Biogen
7.4.1 Biogen Corporate Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Rheumatoid Arthritis Drugs Major Product Offerings
7.4.4 Biogen Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Biogen Key News
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Corporate Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Rheumatoid Arthritis Drugs Major Product Offerings
7.5.4 Boehringer Ingelheim Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Boehringer Ingelheim Key News
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Corporate Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Rheumatoid Arthritis Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Bristol-Myers Squibb Key News
7.7 F. Hoffmann-La Roche
7.7.1 F. Hoffmann-La Roche Corporate Summary
7.7.2 F. Hoffmann-La Roche Business Overview
7.7.3 F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Major Product Offerings
7.4.4 F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.7.5 F. Hoffmann-La Roche Key News
7.8 Johnson and Johnson
7.8.1 Johnson and Johnson Corporate Summary
7.8.2 Johnson and Johnson Business Overview
7.8.3 Johnson and Johnson Rheumatoid Arthritis Drugs Major Product Offerings
7.8.4 Johnson and Johnson Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.8.5 Johnson and Johnson Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Rheumatoid Arthritis Drugs Major Product Offerings
7.9.4 Merck Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.9.5 Merck Key News
7.10 Mitsubishi Tanabe Pharma
7.10.1 Mitsubishi Tanabe Pharma Corporate Summary
7.10.2 Mitsubishi Tanabe Pharma Business Overview
7.10.3 Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Major Product Offerings
7.10.4 Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.10.5 Mitsubishi Tanabe Pharma Key News
7.11 Novartis
7.11.1 Novartis Corporate Summary
7.11.2 Novartis Rheumatoid Arthritis Drugs Business Overview
7.11.3 Novartis Rheumatoid Arthritis Drugs Major Product Offerings
7.11.4 Novartis Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.11.5 Novartis Key News
7.12 Pfizer
7.12.1 Pfizer Corporate Summary
7.12.2 Pfizer Rheumatoid Arthritis Drugs Business Overview
7.12.3 Pfizer Rheumatoid Arthritis Drugs Major Product Offerings
7.12.4 Pfizer Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.12.5 Pfizer Key News
7.13 UCB S.A
7.13.1 UCB S.A Corporate Summary
7.13.2 UCB S.A Rheumatoid Arthritis Drugs Business Overview
7.13.3 UCB S.A Rheumatoid Arthritis Drugs Major Product Offerings
7.13.4 UCB S.A Rheumatoid Arthritis Drugs Sales and Revenue in Global (2016-2021)
7.13.5 UCB S.A Key News
8 Global Rheumatoid Arthritis Drugs Production Capacity, Analysis
8.1 Global Rheumatoid Arthritis Drugs Production Capacity, 2016-2027
8.2 Rheumatoid Arthritis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Rheumatoid Arthritis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Rheumatoid Arthritis Drugs Supply Chain Analysis
10.1 Rheumatoid Arthritis Drugs Industry Value Chain
10.2 Rheumatoid Arthritis Drugs Upstream Market
10.3 Rheumatoid Arthritis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Rheumatoid Arthritis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Rheumatoid Arthritis Drugs in Global Market
Table 2. Top Rheumatoid Arthritis Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Rheumatoid Arthritis Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Rheumatoid Arthritis Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Rheumatoid Arthritis Drugs Sales by Companies, (MT), 2016-2021
Table 6. Global Rheumatoid Arthritis Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Rheumatoid Arthritis Drugs Price (2016-2021) & (USD/Kg)
Table 8. Global Manufacturers Rheumatoid Arthritis Drugs Product Type
Table 9. List of Global Tier 1 Rheumatoid Arthritis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatoid Arthritis Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

AbbVie
Amgen
Bayer
Biogen
Boehringer Ingelheim
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson and Johnson
Merck
Mitsubishi Tanabe Pharma
Novartis
Pfizer
UCB S.A

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE